From Avalon Ventures’ $495M Deal Grew from GSK Quest for Academic Inroads:

Avalon Ventures partner Jay Lichter

Avalon Ventures partner Jay Lichter—

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Video
Fish & Richardson: Patent Law in Regards to AI and Machine Learning
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Fish & Richardson

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Xconomy on Demand

We offer a number of ways to subscribe for free!